Avantor to divest clinical services business to Audax for $650m
Avantor, Inc. (NYSE: AVTR), a leading global provider of essential products and services to the life sciences and advanced technologies industries, has entered into a definitive agreement to sell its clinical services business to Audax Private Equity for approximately $650 million. This strategic move is part of Avantor’s broader effort to optimise its business portfolio […]